Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Growth Rate of the Immunohematology Market?

In recent times, the immunohematology market has seen consistent growth. It’s projected to rise from $2.46 billion in 2024 to $2.57 billion in 2025, marking a compound annual growth rate (CAGR) of 4.6%. The increase during the historic period is largely due to improvements in blood transfusion technology, commonality of blood ailments, enlargement of blood bank facilities, government efforts for blood safety, a surge in surgical procedures, and heightened knowledge regarding the hazards associated with transfusions.

What Growth Rate Is Forecasted for the Immunohematology Market by 2029?

The size of the immunohematology market is projected to experience significant expansion in the upcoming years, with predictions reaching “$3.24 billion by 2029, reflecting a compound annual growth rate (CAGR) of 5.9%. This predicted rise during the forecast term can be linked to factors such as the growing need for point-of-care testing, the introduction of innovative blood products, the development of healthcare infrastructure, genetic tests for blood compatibility, and regulatory backing for blood safety. Major trends expected during this projection period encompass automation, high-throughput systems, methodologies for molecular blood typing, techniques for antibody detection, patient blood management schemes, AI incorporation in analytical processes, and the integration of telemedicine.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10295&type=smp

Which Key Companies Are Shaping the Future of the Immunohematology Market?

Major companies operating in the immunohematology market include Ortho Clinical Diagnostics Inc., Immunocor Inc., Abbott Laboratories, Siemens Healthineers AG, Grifols S.A., Beckman Coulter Inc., Thermo Fisher Scientific Inc., Becton Dickinson and Company, Merck Co. & KGaA, Bio-Rad Laboratories, Sysmex Corporation, Danaher Corporation, Biosystems S.A., Roche Holdings AG, Mindray Medical International Limited, F.Hoffmann La-Roche Ltd., Biotest AG, Cardinal Health Inc., Quotient Limited, DiaSorin S.p.A., Lorne Laboratories Ltd., Biokit S.A., Avox Technologies, Diagnostic Automation/Cortez Diagnostics Inc., Inno-train Diagnostik GmbH, Drucker Diagnostics Inc., Immundia Diagnostics Pvt. Ltd.

Which Factors Are Driving Demand in the Immunohematology Industry?

The immunohematology market’s expansion is anticipated to be driven by the increasing incidence rate of hematological conditions. These disorders, which affect blood and its components such as red and white blood cells, platelets, and plasma, are varied. Immunohematology is critical for effective and safe blood transfusions as it aids in avoiding transfusion reactions due to mismatched blood types or antibodies in the recipient’s blood. Techniques in immunohematology are also utilized in diagnosing and treating diseases associated with the immune system that may affect the hematological system. As an example, Cancer Research UK, a research institution based in the UK, estimates that the number of new leukemia cases rising from hematological disorders is expected to increase from about 12,400 cases in 2023-2025 to nearly 14,500 cases in 2038-2040 in the UK. Consequently, the growth of the immunohematology market is being propelled by the increasing incidence rate of hematological conditions.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=10295&type=smp

How Is the Immunohematology Market Segmented by Several Divisions?

The immunohematology market covered in this report is segmented –

1) By Product: Analyzers And Systems, Reagents

2) By Technology: Biochips, Erythrocyte-Magnetized Technology (Met), Gel Cards, Microplates, Polymerase Chain Reaction (PCR)

3) By Disease: Blood-Related Diseases, HIV, Hepatitis

4) By Application: Pretransfusion Testing, Investigation Of Immune Hemolysis, Perinatal Testing, Blood Group Phenotyping, Leucocyte And Platelet Serology

5) By End User: Blood Banks, Diagnostic And Reference Laboratories, Hospitals, Academic And Research Institutes

Subsegments:

1) By Analyzers And Systems: Blood Typing Analyzers, Cross-Matching Analyzers, Gel Card Systems

2) By Reagents: Blood Grouping Reagents, Antisera, Control Serum

What are the Emerging Market Trends Driving the Growth of the Immunohematology Industry?

Key players in the immunohematology market are concentrating on the creation of pioneering diagnostic tools, specifically soluble recombinant proteins created to counteract the disruption caused by the cancer treatment daratumumab. Soluble recombinant protein, made with recombinant DNA technology and maintains its function in a host cell or solution, makes it suitable for both research and clinical applications. For example, in November 2023, the Spain-based pharmaceutical firm, Grifols, S.A., introduced the Grifols sCD38 solution. This was the first soluble recombinant protein to be developed and was aimed at addressing the issues caused by daratumumab cancer treatment during critical blood transfusion compatibility assessments. It was particularly devised for patients with multiple myeloma. This revolutionary solution prevents daratumumab from bonding with CD38 proteins on red blood cells, providing accurate results for pre-transfusion tests. By enabling more efficient procedures for screening, identifying, and crossmatching, the Grifols sCD38 solution optimizes blood transfusion processes and reduces delays in providing crucial transfusions.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/immunohematology-global-market-report

Which Regions Are Driving Growth in the Immunohematology Market?

North America was the largest region in the immunohematology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global immunohematology market during the forecast period. The regions covered in the immunohematology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10295

This Report Delivers Insight On:

1. How big is the immunohematology market, and how is it changing globally?

2. Who are the major companies in the immunohematology market, and how are they performing?

3. What are the key opportunities and risks in the immunohematology market right now?

4. Which products or customer segments are growing the most in the immunohematology market?

5. What factors are helping or slowing down the growth of the immunohematology market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model